TP53 and hepatocellular carcinoma: HCC is known for its high degree of genetic variability and frequently contains mutations in genes such as TP53 (tumor protein p53) and CTNNB1 (catenin beta 1), and the promoter region of TERT (telomerase reverse transcriptase), which are often considered difficult to target with conventional drugs [18].